newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

STANS, SWITZERLAND / ACCESSWIRE / August 5, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW))) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with ra